Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 LUPUS ERYTHEMATOSUS CELL PHENOMENON IN PATIENTS WITH CHRONIC ULCERATIVE COLITIS.

Literature DB >> 14259422

LUPUS ERYTHEMATOSUS CELL PHENOMENON IN PATIENTS WITH CHRONIC ULCERATIVE COLITIS.

D ALARCON SEGOVIA, T HERSKOVIC, W H DEARING, L G BARTHOLOMEW, J C CAIN, R G SHORTER.

Abstract

Entities: Species

Keywords: ADRENAL CORTEX HORMONES; COLITIS, ULCERATIVE; DIAGNOSIS; LE CELLS; LIVER DISEASES; LIVER FUNCTION TESTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PATHOLOGY; SULFONAMIDES; TOXICOLOGIC REPORT

Mesh：

Substances：

Year: 1965 PMID： 14259422 PMCID： PMC1552226 DOI： 10.1136/gut.6.1.39

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

× No keyword cloud information.

28 in total

1. Further obervations on hepatitis and cirrhosis in young women with positive clot tests for lupus erythematousus.

Authors: L G BARTHOLOMEW; J C CAIN; A H BAGGENSTOSS; A B HAGEDORN
Journal: Gastroenterology Date: 1960-12 Impact factor: 22.682

2. Protein abnormalities in ulcerative colitis patients and their families.

Authors: W R THAYER; H M SPIRO
Journal: Gastroenterology Date: 1963-04 Impact factor: 22.682

3. Autoimmune disease of the thyroid and colon, with a report of a case of chronic ulcerative colitis in association with Hashimoto's disease and penicillin allergy.

Authors: K S BREARLEY; A S SPIERS
Journal: Med J Aust Date: 1962-05-26 Impact factor: 7.738

4. Myasthenia gravis followed by systemic lupus erythematosus. A case report.

Authors: D DENNEY; R L ROSE
Journal: Neurology Date: 1961-08 Impact factor: 9.910

5. Hepatitis, colitis, and lupus manifestations.

Authors: N GRAY; I R MACKAY; L I TAFT; S WEIDEN; I J WOOD
Journal: Am J Dig Dis Date: 1958-07

6. Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases.

Authors: A M HARVEY; L E SHULMAN; P A TUMULTY; C L CONLEY; E H SCHOENRICH
Journal: Medicine (Baltimore) Date: 1954-12 Impact factor: 1.889

7. The relationship of chronic ulcerative colitis and cirrhosis.

Authors: F W HOFFBAUER; J S McCARTNEY; C DENNIS; K KARLSON
Journal: Ann Intern Med Date: 1953-08 Impact factor: 25.391

8. DEMONSTRATION OF CIRCULATING ANTINUCLEAR GLOBULINS IN ULCERATIVE COLITIS.

Authors: P Calabresi; W R Thayer; H M Spiro
Journal: J Clin Invest Date: 1961-12 Impact factor: 14.808

9. Severe reactions to long-acting sulfonamides. Erythema multiforme exudativum and lupus erythematosus following administration of sulfamethoxypyridazine and sulfadimethoxine.

Authors: M L RALLISON; J O'BRIEN; R A GOOD
Journal: Pediatrics Date: 1961-12 Impact factor: 7.124

LUPUS ERYTHEMATOSUS CELL PHENOMENON IN PATIENTS WITH CHRONIC ULCERATIVE COLITIS.

1. Further obervations on hepatitis and cirrhosis in young women with positive clot tests for lupus erythematousus.

2. Protein abnormalities in ulcerative colitis patients and their families.

3. Autoimmune disease of the thyroid and colon, with a report of a case of chronic ulcerative colitis in association with Hashimoto's disease and penicillin allergy.

4. Myasthenia gravis followed by systemic lupus erythematosus. A case report.

5. Hepatitis, colitis, and lupus manifestations.

6. Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases.

7. The relationship of chronic ulcerative colitis and cirrhosis.

8. DEMONSTRATION OF CIRCULATING ANTINUCLEAR GLOBULINS IN ULCERATIVE COLITIS.

9. Severe reactions to long-acting sulfonamides. Erythema multiforme exudativum and lupus erythematosus following administration of sulfamethoxypyridazine and sulfadimethoxine.

10. Life histories of patients with chronic ulcerative colitis: a review of 2,000 cases.

1. Discrete ulcerations of the rectum and sigmoid.

2. Auto-immune reactions in ulcerative colitis.

Review 3. Sulfasalazine. Adverse effects and desensitization.

4. Sulphasalazine-induced cerebral lupus erythematosus.

5. Combination therapy for rheumatoid arthritis and drug-induced systemic lupus erythematosus.

6. Raynaud's phenomenon induced by sulphasalazine.

7. Sulphasalazine-induced systemic lupus erythematosus in a patient with Sjögren's syndrome.